Social Media on Prescription? A randomized trial investigating if a health platform could improve patient outcomes (SMOP)

 

The overall aim with this study is to get a deeper understanding of the potential benefits with a health platform for patients diagnosed with colorectal cancer. 

Hypotheses

Our main hypotheses are that patients who are active on a health platform will:

-      Have an improved self-efficacy for coping as measured by CBI-B?

-       Increase postoperative morbidity.

Endpoints

Primary:

  • Perception of empowerment measured by CBI-B.
  • Knowledge of disease.

Secondary:

  • Compliance to treatment and health advices.
  • Quality of life.
  • The perceived health impact by the Health platform.
  • The usability of the Health platform usability.

Inclusion/exclusion

Inclusion criteria:

All patients diagnosed or treated for colorectal cancer within the last year at the including hospitals will be possible to include in the study. Patients that find the forum through the internet can also be included, regardless of treating hospital.

Exclusion criteria:

Inability to give informed consent or speaking and reading the Swedish language. No possibility to use a health platform.

Inclusion of patients:

Aiming at including 400 patients.

Documents

Protocol (click on name to view/download): SMOP

Contact

Principal investigator:

Eva Angenete (PI: Medicine) & Martin Gellerstedt (PI: Informatics)

Deputy principal investigator:

Tomas Lindroth (Informatics)

Questions:

PI Eva Angenete (eva.angenete@gu.se) or research nurse Jane Heath (jane.heath@vgregion.se)